Selvas Healthcare셀바스헬스케어
208370 · KOSDAQ · ₩208370 · 셀바스헬스케어
- Market cap
- ₩59B
- Enterprise value
- ₩38B
- P/E
- 6.7×
- P/B
- 0.8×
- Dividend yield
- 0.0%
- ROE
- 11.5%
- Net margin
- 27.4%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−69.6% from the high
₩2,130Today: ₩2,265 – ₩2,370₩7,490
Returns
- 1W−5.0%
- 1M−2.8%
- 3M−14.9%
- 6M−48.9%
- YTD−60.8%
- 1Y−36.0%
- Volume today
- 185,093
- 0.3× the 20-day average
- Traded today
- ₩427M
- Listed shares
- 25,740,564
- EPS (12 months)
- ₩338
- Earnings yield 14.8%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 27 of 100 (50 is a normal day for this stock).
- MomentumFlat-1.7% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Selvas Healthcare stock overview
Selvas Healthcare (셀바스헬스케어, KRX: 208370) is listed on KOSDAQ, in the Medical & precision devices sector. Dasan Zhone-style digital healthcare company with two divisions: ACCUNIQ, which makes medical diagnostic devices such as body composition analyzers and fully automatic blood pressure monitors, and HIMS, which makes assistive technology for visually impaired people such as braille information terminals (Hansone), screen magnifiers and audio book players. Its shares closed at ₩2,280 on Oct 27, 2026, down 2.77% on the day, giving it a market value of ₩59B.
Key facts
- Market cap
- ₩59B
- Sector
- Medical & precision devices
- Latest price change
- −2.77%
- As of
- Oct 27, 2026
- Main business
- Dasan Zhone-style digital healthcare company with two divisions: ACCUNIQ, which makes medical diagnostic devices such as body composition analyzers and fully automatic blood pressure monitors, and HIMS, which makes assistive technology for visually impaired people such as braille information terminals (Hansone), screen magnifiers and audio book players.
Quick answers about Selvas Healthcare
- What does Selvas Healthcare do?
- Dasan Zhone-style digital healthcare company with two divisions: ACCUNIQ, which makes medical diagnostic devices such as body composition analyzers and fully automatic blood pressure monitors, and HIMS, which makes assistive technology for visually impaired people such as braille information terminals (Hansone), screen magnifiers and audio book players. The company sells through direct sales and domestic and overseas distributor networks, and has subsidiaries in the United States and China to target overseas markets.
- What is the market cap of Selvas Healthcare?
- The market capitalisation of Selvas Healthcare was ₩59B at the close on Oct 27, 2026.
- Who are the largest shareholders of Selvas Healthcare?
- According to the latest official filings, the largest reported holders are Selvas AI (40.12%, as of Dec 18, 2025); Korea Securities Finance (4.11%, as of Jul 9, 2026); National Pension Service (0.63%, as of Dec 31, 2023).
- When is the next earnings report from Selvas Healthcare?
- Korean companies rarely announce results dates in advance. Based on when Selvas Healthcare filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Selvas Healthcare?
- Yes. The National Pension Service held 0.63% of Selvas Healthcare shares as of Dec 31, 2023.
Company profile
Dasan Zhone-style digital healthcare company with two divisions: ACCUNIQ, which makes medical diagnostic devices such as body composition analyzers and fully automatic blood pressure monitors, and HIMS, which makes assistive technology for visually impaired people such as braille information terminals (Hansone), screen magnifiers and audio book players. The company sells through direct sales and domestic and overseas distributor networks, and has subsidiaries in the United States and China to target overseas markets.
Written by AI from the company's latest annual report.
- Korean name
- 셀바스헬스케어
- CEO
- 유병탁
- Founded
- Oct 2014
- Listed
- Dec 2014
- Listed shares
- 25,740,564
- Fiscal year ends
- Month 12
- Website
- www.selvashealthcare.com
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Amended: Half-year report (Jun 2026)Sep 30, 2026
- Added attachment: Half-year report (Jun 2026)Aug 14, 2026
- 5%+ holding reportJul 9, 2026
- Quarterly report (Mar 2026)May 15, 2026
- Amended: Annual report (Dec 2025)May 15, 2026
Titles in Korean until English translations are added.
Also known as: Selvas Healthcare / 셀바스헬스케어 / 208370 / KRX:208370
Source: KRX statistical information